InnoCare Sets 26 October Board Meeting to Review Nine-Month 2026 Results
Bulletin Express
Oct 12
InnoCare Pharma Limited will convene its Board of Directors on 26 October 2026 to consider and approve the unaudited third-quarter results covering the nine months ended 30 September 2026. The agenda also includes authorizing the release of the corresponding financial report to the market.
The meeting will be chaired by Executive Director Dr. Jisong Cui, with participation from Executive Director Dr. Renbin Zhao, Non-Executive Directors Dr. Yigong Shi and Mr. Ronggang Xie, and Independent Non-Executive Directors Ms. Lan Hu, Dr. Dandan Dong, and Prof. Kunliang Guan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.